Android app Apple app link

Avidity Biosciences (RNA) Soars 42% on $12-Billion Novartis Merger

By Yahoo! Finance   |   1 month ago
Avidity Biosciences (RNA) Soars 42% on $12-Billion Novartis Merger

Avidity Biosciences (NASDAQ:RNA) surged by 42.1% after a $12 billion merger plan with Novartis AG. The acquisition aims to boost Novartis's neuroscience franchise. Shareholders will receive SpinCo shares or cash.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.